| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 110589-97-4 | Methyl 2-Oxa-3-Azabicyclo[2.2.2]Octane-3-Carboxylate | C8H13NO3 |
| 110590-00-6 | 2,2,2-Trifluoro-1-(2-Oxa-3-Azabicyclo[2.2.2]Oct-3-Yl)Ethanone | C8H10F3NO2 |
| 110590-04-0 | 1-(1-Methyl-2-Oxa-3-Azabicyclo[2.2.2]Oct-3-Yl)Ethanone | C9H15NO2 |
| 110590-05-1 | 1-Methyl-2-Oxa-3-Azabicyclo[2.2.2]Octane-3-Carbaldehyde | C8H13NO2 |
| 110590-34-6 | 1-(1-Methyl-2-Oxa-3-Azabicyclo[2.2.2]Oct-5-En-3-Yl)Ethanone | C9H13NO2 |
| 110590-35-7 | 1-Methyl-2-Oxa-3-Azabicyclo[2.2.2]Oct-5-Ene-3-Carbaldehyde | C8H11NO2 |
| 110590-39-1 | (2S)-1-(2-Aminoacetyl)-N-[(2R)-1-[[2-[[(2S)-3-Methyl-1-Oxobutan-2-Yl]Amino]-2-Oxoethyl]Amino]-1-Oxo-3-Phenylpropan-2-Yl]-2,3-Dihydropyrrole-2-Carboxamide | C23H31N5O5 |
| 110590-60-8 | L-Cysteinyl-L-alpha-Aspartyl-L-Prolylglycyl-L-Tyrosyl-L-Isoleucylglycyl-L-Seryl-L-Arginine | C40H62N12O14S |
| 110590-61-9 | L-Cysteinyl-L-alpha-Aspartyl-L-Prolylglycyl-L-Tyrosyl-L-Isoleucylglycyl-L-Seryl-L-Argininamide | C40H63N13O13S |
| 110590-63-1 | Glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginine | C28H45N9O9 |
| 110590-64-2 | Tyrosinyl-isoleucinyl-glycinyl-serinyl-arginine | C26H42N8O8 |
| 110590-65-3 | L-Tyrosyl-L-isoleucylglycyl-L-seryl-L-argininamide | C26H43N9O7 |
| 110590-81-3 | 2,9-Bis(1-ethylpropyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone | C34H30N2O4 |
| 110590-84-6 | 2,9-Bis(1-Hexylheptyl)-Anthra[2,1,9-Def:6,5,10-d'e'f']Diisoquinoline-1,3,8,10(2H,9H)-Tetrone | C50H62N2O4 |
| 110594-91-7 | Methyl 3-O-Benzyl-6-Deoxy-2-O-Methylhexopyranoside | C15H22O5 |
| 110599-19-4 | Hydroxy{[(4-Methylphenyl)Acetyl]Amino}Acetic Acid | C11H13NO4 |
| 110599-27-4 | Bis[(methoxycarbonyl)amino]acetic acid | C6H10N2O6 |
| 110605-28-2 | Acetylcysteine(asparaginyl-alanyl-asparaginyl-proline)3 | C53H81N19O21S |
| 110605-64-6 | N-(4,5-Dihydro-1H-Imidazol-2-Yl)-4-Fluoro-1,3-Dihydroisoindol-2-Amine | C11H13FN4 |
| 110611-21-7 | (alphaR)-4-Chloro-alpha-ethylbenzenemethanol | C9H11ClO |
| 110611-91-1 | tert-Butyl 4-bromobutanoate | C8H15BrO2 |
| 110612-30-1 | (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-Dimethyl-17-[(2R,5S)-5,6,7-Trihydroxy-6-Methylheptan-2-Yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1H-Cyclopenta[a]Phenanthrene-3,7,12-Triol | C27H48O6 |
| 110615-13-9 | 1,2-Dimethoxyethane - Trichloroniobium (1:1) | C4H10Cl3NbO2 |
| 110615-47-9 | Lauryl polyglucose | C18H36O6 |
| 110622-75-8 | 10-Fluoro-7-Thiophen-2-Yl-1,2,3,4,4a,5-Hexahydropyrazino[1,2-a][1,4]Benzodiazepine | C16H16FN3S |
| 110623-33-1 | 5-(3-Fluorophenyl)-2,4-Dimethyl-1,2,4-Triazole-3-Thione | C10H10FN3S |
| 110623-35-3 | 5-(2,4-Difluorophenyl)-2,4-Dimethyl-1,2,4-Triazole-3-Thione | C10H9F2N3S |
| 110623-40-0 | 5-(1,3-Benzodioxol-5-Yl)-2,4-Dimethyl-1,2,4-Triazole-3-Thione | C11H11N3O2S |
| 110623-72-8 | Epimedin A | C39H50O20 |
| 110623-73-9 | Epmedin B | C38H48O19 |
| 110626-61-4 | {3-[2-(Dimethylamino)Ethyl]-1H-Indol-5-Yl}Acetonitrile | C14H17N3 |
| 110629-41-9 | N-[2-[4-[Di(Phenyl)Methyl]Piperazin-1-Yl]Ethyl]-2,6-Dimethyl-3-Nitropyridin-4-Amine | C26H31N5O2 |
| 110637-40-6 | N-[(2-Propenyloxy)carbonyl]-glycine compd. with N-cyclohexylcyclohexanamine (1:1) | C12H23N.C6H9NO4 |
| 110637-43-9 | N-[(Allyloxy)Carbonyl]-L-Phenylalanine - N-Cyclohexylcyclohexanamine (1:1) | C25H38N2O4 |
| 110637-52-0 | N-Boc-N'-allyloxycarbonyl-D-lysine dicyclohexylamine salt | C27H49N3O6 |
| 110637-53-1 | N2-Allyloxycarbonyl-N6-(tert-butoxycarbonyl)-L-lysine dicyclohexyl ammonium salt | C15H26N2O6.C12H23N |
| 110638-01-2 | 1-Chloro-3-[[4-(4-Morpholinyl)-1,2,5-Thiadiazol-3-Yl]Oxy]-2-Propanone | C8H10ClN3O3S |
| 110638-68-1 | 4-O-beta-D-Galactopyranosyl-D-gluconic acid calcium salt (2:1) dihydrate | 2(C12H21O12).Ca.2(H2O) |
| 110642-44-9 / 119760-73-5 | Epmedin C | C39H50O19 |
| 110646-15-6 | O3-Ethyl O5-Methyl 2-(2-Aminoethylsulfanylmethyl)-6-Methyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3,5-Dicarboxylate | C20H25N3O6S |
| 110649-85-9 | Triazolium-bis(triazole)tetrachlororuthenate(III) | C6H9Cl4N9Ru |
| 110652-05-6 | D-Alanyl-D-Alanine | C6H12N2O3 |
| 110652-72-7 | (E)-3-[(6R)-4,6-Dimethoxy-11-Oxo-5,6,6a,7-Tetrahydropyrrolo[5,1-c][1,4]Benzodiazepin-8-Yl]-N,N-Dimethylprop-2-Enamide | C19H23N3O4 |
| 110652-73-8 | (E)-3-[(6R)-6-Hydroxy-4-Methoxy-11-Oxo-5,6,6a,7-Tetrahydropyrrolo[5,1-c][1,4]Benzodiazepin-8-Yl]-N,N-Dimethylprop-2-Enamide | C18H21N3O4 |
| 110654-66-5 | 1-(3-Nitrophenyl)methanesulfonamide | C7H8N2O4S |
| 110656-00-3 | 1,1,2-Trimethyl-2-(1-Propyn-1-Yl)Cyclobutane | C10H16 |
| 110656-67-2 | N-[2-Methyl-4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)-2-oxiranemethanamine | C16H21NO4 |
| 110658-38-3 | (4S,5S)-4-Hydroxy-5-(Hydroxymethyl)-L-Proline | C6H11NO4 |
| 110658-87-2 | 2,2,2-Trifluoro-1-(2-Oxa-3-Azabicyclo[2.2.2]Oct-5-En-3-Yl)Ethanone | C8H8F3NO2 |
| 110659-91-1 | Psammaplin A | C22H24Br2N4O6S2 |